Literature DB >> 17088065

alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.

Alessandro Biasone1, Paolo Tortorella, Cristina Campestre, Mariangela Agamennone, Serena Preziuso, Marika Chiappini, Elisa Nuti, Paolo Carelli, Armando Rossello, Fernando Mazza, Carlo Gallina.   

Abstract

(R)-alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates attain nM potency against several MMPs and are the most effective inhibitors based on phosphonate as zinc binding group. Since their preparation by direct N-acylation of expensive, enantiopure, alpha-aminophosphonic acids proceeds in low yields, we devised and evaluated a stereoselective and straightforward method of synthesis that avoids the unfavourable step of N-acylation. The key intermediate (R)-4-bromophenylsulfonylamino 2-methylpropyl phosphonate 9 was obtained by highly stereoselective addition of dibenzylphosphite to the enantiopure (S)-N-isobutylidene-p-bromobenzenesulfinamide 3, followed by oxidation with m-CPBA. Suzuki coupling of 9 with the desired arylboronic acids, gave the expected biphenylsulfonylamino derivatives in satisfactory yields. Liberation of the phosphonic group by hydrogenolysis led to the desired (R)-alpha-biphenylsulfonylamino 2-methylpropyl phosphonates 14a-i. Screening of the new compounds on MMP-1, -2, -3, -7, -8, -9, -13 and -14 showed IC(50) in the range of nM in most cases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17088065     DOI: 10.1016/j.bmc.2006.10.047

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  7 in total

Review 1.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

2.  An Overview of Stereoselective Synthesis of α-Aminophosphonic Acids and Derivatives.

Authors:  Mario Ordóñez; Haydée Rojas-Cabrera; Carlos Cativiela
Journal:  Tetrahedron       Date:  2009-01-03       Impact factor: 2.457

Review 3.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

Authors:  Arda Kucukguven; Raouf A Khalil
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

4.  In vitro comparison of new bisphosphonic acids and zoledronate effects on human gingival fibroblasts viability, inflammation and matrix turnover.

Authors:  Marianna De Colli; Paolo Tortorella; Guya Diletta Marconi; Mariangela Agamennone; Cristina Campestre; Marilena Tauro; Amelia Cataldi; Susi Zara
Journal:  Clin Oral Investig       Date:  2015-12-22       Impact factor: 3.573

5.  Dual targeting of cancer-related human matrix metalloproteinases and carbonic anhydrases by chiral N-(biarylsulfonyl)-phosphonic acids.

Authors:  Grazia Luisi; Guido Angelini; Carla Gasbarri; Antonio Laghezza; Mariangela Agamennone; Fulvio Loiodice; Claudiu T Supuran; Cristina Campestre; Paolo Tortorella
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

6.  Synthesis, Spectroscopic Characterization, and In Vitro Antibacterial Evaluation of Novel Functionalized Sulfamidocarbonyloxyphosphonates.

Authors:  Abdeslem Bouzina; Khaoula Bechlem; Hajira Berredjem; Billel Belhani; Imène Becheker; Jacques Lebreton; Marc Le Borgne; Zouhair Bouaziz; Christelle Marminon; Malika Berredjem
Journal:  Molecules       Date:  2018-07-10       Impact factor: 4.411

Review 7.  Phosphonic acid: preparation and applications.

Authors:  Charlotte M Sevrain; Mathieu Berchel; Hélène Couthon; Paul-Alain Jaffrès
Journal:  Beilstein J Org Chem       Date:  2017-10-20       Impact factor: 2.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.